First Trust Advisors’s NRC Health Common Stock NRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
– Sell
-39,571
Closed -$1.76M – 2401
2023
Q3
$1.76M Sell
39,571
-13,862
-26% -$605K ﹤0.01% 1738
2023
Q2
$2.32M Buy
+53,433
New +$2.35M ﹤0.01% 1630
2021
Q4
– Sell
-16,863
Closed -$711K – 2571
2021
Q3
$711K Buy
+16,863
New +$849K ﹤0.01% 2163
2020
Q4
– Sell
-16,011
Closed -$788K – 2386
2020
Q3
$788K Sell
16,011
-71
-0.4% -$3.93K ﹤0.01% 1861
2020
Q2
$936K Sell
16,082
-10,371
-39% -$548K ﹤0.01% 1763
2020
Q1
$1.2M Sell
26,453
-13,947
-35% -$838K ﹤0.01% 1524
2019
Q4
$2.66M Buy
+40,400
New +$2.47M ﹤0.01% 1414

Other funds holding NRC

First Trust Advisors's NRC Position: Q4 2023 in Review

First Trust Advisors sold out of NRC Health Common Stock (NRC) in Q4 2023, closing a stake of 39,571 shares — an estimated $1.76M sold.

First Trust Advisors first reported a position in NRC in Q4 2019 and held it in 7 quarters. The position peaked at $2.66M in Q4 2019. 132 funds tracked by Wall St. Rank hold NRC as of Q4 2023.

  • First Trust Advisors reported no remaining NRC Health Common Stock position as of Q4 2023 after selling out during the quarter.
  • First Trust Advisors sold 39,571 NRC Health Common Stock shares in Q4 2023, an estimated $1.76M.
  • First Trust Advisors first reported a position in NRC Health Common Stock in Q4 2019 and held it in 7 quarters.
  • First Trust Advisors's NRC Health Common Stock position peaked at $2.66M in Q4 2019.
  • 132 funds tracked by Wall St. Rank held NRC Health Common Stock as of Q4 2023.

Based on First Trust Advisors's 13F filing for Q4 2023, filed 13 Feb 2024.